(Q35732436)

9 August 2017

1 reference

title

Role of interleukin-1 in infectious diseases (English)

1 reference

9 August 2017

1 reference

1

Dinarello CA

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1506003

3 October 2022

publication date

1 June 1992

1 reference

9 August 2017

published in

Immunological Reviews

1 reference

9 August 2017

volume

127

1 reference

9 August 2017

page(s)

119-146

1 reference

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Interleukin-1 and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Occurrence of interleukin-1 in cerebrospinal fluid of the conscious cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Native interleukin 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Soluble cytokine receptors are present in normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Purification and characterization of a novel soluble receptor for interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Preliminary report: effects of interleukin-1 on platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Both inflammatory and endocrine mediators stimulate host responses to sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01411.X

10.1111/J.1600-065X.1992.TB01411.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference